Triple-negative breast cancer (TNBC) refers to breast cancer with negative estrogen receptor (ER), progesterone receptor (PR) and proto-oncogene Her-2, accounting for 15–20% of all pathological types of breast cancer, with a special biological behavior and clinical pathological characteristics [3]. This evidence concerns the gene ESR1 and breast cancer.